Resveratrol protects vascular endothelial cell from Ox-LDL-induced reduction in antithrombogenic activity

Chinese Journal of Physiology

Volumn 50, Issue 1, 2007, Pages 22-28

  Chen, Ying Jen ^a   Wang, Jong Shyan ^b   Chow, Shu Er ^c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Endothelial cells; Nitric oxide synthase; Nonthrombogenecity; Ox LDL; Trans resveratrol

Indexed keywords

CALCIUM ION; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; RESVERATROL; ANTIOXIDANT; CALCIUM; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; STILBENE DERIVATIVE;

ANTITHROMBOGENIC ACTIVITY; ARTICLE; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM CELL; GENE REPRESSION; HUMAN; HUMAN CELL; PROTEIN CONTENT; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM; COCULTURE; DRUG ANTAGONISM; DRUG EFFECT; INTRACELLULAR MEMBRANE; METABOLISM; OSMOLARITY; PHYSIOLOGY; THROMBOCYTE; THROMBOSIS;

ANTIOXIDANTS; BLOOD PLATELETS; CALCIUM; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIC GMP; ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR MEMBRANES; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OSMOLAR CONCENTRATION; PLATELET AGGREGATION; STILBENES; THROMBOSIS;

EID: 34147156725     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Blair, A., Shaul, P.W., Yuhanna, L.S., Conrad, P.A. and Smart, E.J. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J. Biol. Chem. 274: 32512-32519, 1999.
2. Chen, J.K., Hoshi, H., McClure, D.B. and Mckeehan, W.L. Role of lipoproteins in growth of human adult arterial endothelial and smooth muscle cells in low lipoprotein-deficient serum. J. Cell. Physiol. 129: 207-214, 1986.
3. Chin, J.H., Azhar, S. and Hoffman, B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 89: 10-18, 1992.
4. Chow, S.E., Lee, R.S., Shih, S.H. and Chen, J.K. Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism. FASEB J. 12: 823-830, 1998.
5. Dewitt, D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta 1083: 121-134, 1991.
6. Diaz, M.N., Frei, B., Vita, J.A. and Keaney, J.F. Antioxidants and atherosclerotic heart disease. N. Eng. J. Med 337: 408-416, 1997.
7. Esterbauer, H., Gebicki, J., Pyhl, H. and Jurgen, G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radi. Biol. Med. 13: 341-390, 1992.
8. Frankel, E.N., Waterhouse, A.L. and Kinsella, J.E. Inhibition of human LDL oxidation by resveratrol. Lancet 341:1103-1104, 1993.
9. Fuhrman, B., Lavy, A. and Aviram, M. Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to lipid peroxidation. Am J. Clin. Nutr. 61:549-554, 1995.
10. Havel, R.J., Eder, H.A. and Bradgon, J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353, 1995.
11. Haynes, W.G., Noon, J.P., Walker, B.R. and Webb, D.J. Inhibition of nitric oxide synthesis increases blood pressure in healthy human. J. Hypertens. 11: 1375-1380, 1993.
12. Hirata, K., Miki, N., Kuroda, Y., Sakoda, T., Kawashima, S. and Yokoyama, M. Low concentration of oxidized low-density lipoprotein nd lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ. Res. 76: 958-962, 1995.
13. Holvoet, P. and Collen, D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 8: 1279-1284, 1994.
14. Hseih, T.C., Juan, G., Darzynkiewicz, Z. and Wu, J.M. Resveratrol increase nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2. Cancer Res. 59: 2596-2601, 1999.
15. Janero, D.R. Malonaldehyde and thiobarbituric acid-reactivity as dignostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad. Biol. Med. 9: 515-540, 1990.
16. Jen, C.J., Chen, H.I., Lai, K. and Usami, S. Changes in cytosolic calcium concentrations and cell morphology in single platelets adhered to fibrinogen-coated surface under flow. Blood 87: 3775-3782, 1996.
17. Kugiyama, K, Kerns, S.A., Morrisett, J.D., Roberts, R. and Henry, P. D. Impairement of endothelium-dapendent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160-162, 1990.
18. Liao, J.K., Shin, W.S., Lee, W.Y. and Clark, S.L. Oxidized low density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270: 319-324, 1995.
19. Lowry, O.J., Rosenberough, N.J., Farr, A.L. and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
20. Minuz, P., Lechi, C., Gaino, S., 'Bonapace, S., Fontana, L., Garbin, U., Paluani, F., Cominacini, L., Zatti, M. and Lechi, A. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells. Thromb. Haemost. 74:1175-1179, 1995.
21. Moncada, S., Higgs, E.A. and Hodson, H.F. The L-arginine: nitric oxide pathway. J. Cardiovasc. Pharmacol. 17: S1-S9, 1991.
22. Moncada, S., Palmer, R.M.J. and Higgs, E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol. Res. 43: 109-142, 1991.
23. Nolte, C., Eigenthaler, M., Schanzenbacher, P. and Walter. U. Endothelial cell-dependent phosphorylation of a platelet protein mediated by cAMP- and cGMP-elevating factors. J. Biol. Chem. 266: 14808-14812, 1991.
24. Ohkawa, H., Ohishi, N. and Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbitutric acid reaction. Anal. Biochem. 95: 351-358, 1979.
25. Pace-Asciak, C.R., Hahn, S., Diamandis, E.P., Soleas, G. and Goldberg, D.M. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clinical Chimica. Acta. 235: 207-219, 1995.
26. Plane, K., Bruckdorfer, K.R., Bruckdorfer, R., Kerr, P., Steuer, A. and Jacobs, M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br. J. Pharmacol. 105: 216-222, 1992.
27. Pohl, U., Heydari, N. and Galle, J. Effects of LDL on intracellular flee calcium and nitric oxide-dependent cGMP formation in porcine endothelial cells. Atherosclerosis 117: 169-178, 1995.
28. Quyyumi, A.A., Dakak, N., Andrews, N.P., Husain, S., Arora, S., Gilligan, D.M. and Panza, J.A. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atheroselerosis. J. Clin. Invest. 95: 1747-1755, 1995.
29. Ramasamy, S., Parthasarathy, S. and Harrison, D.G. Regulation of endothelial nitric oxide synthase gene expression by oxidized linoleic acid. J. Lipid Res. 39: 268-276, 1998.
30. Simon, B.C., Cunningham, L.D. and Cohen, R.A. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig Coronary artery. J. Clin. Invest. 86: 75-79, 1990.
31. Steinberg, D. Oxidative modification of LDL and atherogenesis. Circulation95: 1062-1071, 1997.
32. Steven, P.A., Goss, B. and Kalyanararaman, N.H. Antioxidant effects of nitric oxide and nitric oxide donor compounds on low-density lipoprotein oxidation. Methods in Enzymo. 301: 444-453, 1999.
33. Tanner, F.C., Noll, G., Boulanger, C.M. and Luscher, T.F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation 83: 2012-2020, 1991.
34. Thomas, A.P. and Delaville, F. The use of fluorescent indicators for measurements of cytosolic free calcium concentration in cell populations and single cells. In: McCormark JG, Cobbold PH, eds. Cellular Calcium-A Practical Approach. New York: Oxford University Press; pp. 1-53, 1991.
35. Vane, J.R., Anggard, E.E. and Botting, R.M. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323: 27-36, 1990.
36. Wang, J.S., Lin, C.C., Chen, J.K. and Wong, M.K. Role of chronic exercise in decreasing oxidized LDL-potentiated platelet activation by enhancing platelet-derived NO release and bioactivity in rats. Life Sci. 66: 1937-1948, 2000.
37. Wink, D.A., Miranda, K.M., Espey, M.G., Pluta, R.M., Hewett, S.J., Colton, C., Vitek, M., Feelisch, M. and Grisham, M.B. Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox. Signal 3: 203-213, 2001
38. Witztum, J.L. The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795, 1994.